Skip to main content

Cost-effective reimbursement analysis for medical technologies in Europe

Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 34 EU countries

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

NICE opened a consultation on the updated health technology evaluations manual

On June 27, 2023, NICE launched a consultation on the updated health technology evaluation process manual, initially published in January 2022.

The first part of this consultation is related to the proportionate approach to technology appraisals. Through this approach, NICE makes light-touch, faster evaluations of simpler, low-risk treatments, which allows producing rapid guidance for these topics. NICE developed this approach during 2022-2023, and now details are incorporated into the NICE health technology evaluations manual.

The second part of this consultation is on a revised approach to updating technology appraisals for COVID-19 medicines.

The deadline for comments submission is July 25, 2023.

See more information here and here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.